David Michael Nanus, M.D. | Patient Care

Dr. David Nanus, M.D.

Claim this profile

Weill Cornell Medicine

Studies Prostate Cancer
6 reported clinical trials
10 drugs studied

Area of expertise

1

Prostate Cancer

David Nanus, M.D. has run 6 trials for Prostate Cancer. Some of their research focus areas include:

Stage IV
MET positive
KIT positive

Affiliated Hospitals

Image of trial facility.

Weill Cornell Medicine

Image of trial facility.

Weill Cornell Medical Center

Clinical Trials David Nanus, M.D. is currently running

Image of trial facility.

225Ac-J591 + 177Lu-PSMA

for Prostate Cancer

This trial tests two special drugs that deliver radiation directly to prostate cancer cells. It targets men with advanced prostate cancer that doesn't respond to hormone therapy. The drugs work by finding and attaching to cancer cells, then releasing radiation to destroy them. A drug that delivers radioactive isotopes to specific cancer cells has been shown to prolong the lives of men with advanced prostate cancer.

Recruiting

2 awards

Phase 1

9 criteria

Image of trial facility.

TVB-2640 + Enzalutamide

for Prostate Cancer

The purpose of this study is to determine what effects (good and bad) Enzalutamide and TVB-2640 have in the treatment of prostate cancer whose prostate cancer has spread to other parts of their body and that has not gotten better with previous treatment. This study is a Phase I clinical trial. Phase I clinical trials test the side effects of an investigational drug or an investigational combination with another drug. "Investigational" means that the drug is still being studied and research doctors are trying to find out more about it. Although Enzalutamide is already being used to treat men with prostate cancer, combining Enzalutamide with TVB-2640 together in patients with prostate cancer is considered experimental. This research study is being done because additional effective treatments are needed for prostate cancer that has spread and is growing despite hormone suppression. By doing this study, the investigators hope to learn if combining Enzalutamide with TVB-2640 can be done safely. Participation in this research will last about 12 to 24 months after enrollment.

Recruiting

1 award

Phase 1

More about David Nanus, M.D.

Clinical Trial Related

5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments David Nanus, M.D. has experience with

  • 225Ac-J591
  • General Nutritional Counseling
  • Whole-food, Plant-Based Diet
  • BMS-986253
  • Degarelix
  • Nivolumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does David Nanus, M.D. specialize in?

Is David Nanus, M.D. currently recruiting for clinical trials?

Are there any treatments that David Nanus, M.D. has studied deeply?

What is the best way to schedule an appointment with David Nanus, M.D.?

What is the office address of David Nanus, M.D.?

Is there any support for travel costs?